Hongbo Xin

2.4k citations
64 papers · 1.8k indexed · 1 hit paper · h-index 21

Hongbo Xin

64 papers receiving 1.8k citations

Hit Papers

Recent Advances in Nanozymes: From Matters to Bioapplicat...3782021202620222024100200300

Peers

Hongbo Xin
Comparison fields: 5 of 125
  • Rehabilitation 111
  • Geriatrics and Gerontology 46
  • Cancer Research 176
  • Pharmaceutical Science 71
  • Genetics 119
Replace Bingwen Zou with:
Bingwen Zou China
Panghu Zhou China
Mei Zhang China
Shanshan Ma China
Yunna Chen China
Yunyun Xu China
Xin Qin China
Xiaoli Ma China
Abbas Ebrahimi‐Kalan Iran
Xiawei Wei China
Hongbo Xin relative to Bingwen Zou China Bingwen Zou's profile →
Citations per field
00.5×2.8×
Bingwen Zou · 1×
Citations per year

Countries citing papers authored by Hongbo Xin

Since Specialization
Citations

This map shows the geographic impact of Hongbo Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbo Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbo Xin more than expected).

Fields of papers citing papers by Hongbo Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbo Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbo Xin. The network helps show where Hongbo Xin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hongbo Xin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hongbo Xin Line = papers co-authored together Hongbo Xin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20249
3 202317
4 20236
5 202241
6 202269
7
Recent Advances in Nanozymes: From Matters to Bioapplicationsbreakdown →
2021378
8 202116
9 20213
10 20207
11 201913
12 20192
13 201938
14 2019152
15 20183
16 201825
17 201837
18 201515
19 201555
20 201414

About Hongbo Xin

Hongbo Xin is a scholar working on Rehabilitation, Health Informatics and Pharmaceutical Science, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Wound Healing and Treatments (6 papers), Pancreatic function and diabetes (5 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Laser Applications in Dentistry and Medicine (4 papers), Advancements in Transdermal Drug Delivery (4 papers), Hippo pathway signaling and YAP/TAZ (4 papers), Skin Protection and Aging (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Rehabilitation (111 citations), Geriatrics and Gerontology (46 citations) and Cancer Research (176 citations). Hongbo Xin has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Ke‐Yu Deng, Zenan Hu, Qionglin Liang, Yongjian Ai, Hongbin Sun, Xiaoping Liang, Yisong Qian, Xiaolei Wang, Xiao‐Hui Guan and Lingfang Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Advanced Functional Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026